Octant Bio: Funding, Investors & Team (Sep 2026)
Octant Bio is a developer of synthetic technology used to improve health and treat disease. Its technology uses synthetic biology, genome engineering, next-generation sequencing, and computational tools to simultaneously measure the activity of thousands of receptor pathways in human cells that enable scientists to apply machine learning methods to engineer small molecules that interact with multiple receptors and unlock a new potential to treat complex diseases.
Octant Bio has raised $110M across 2 funding rounds on record, the most recent a Series B of $80.0M announced in Apr 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Octant Bio Company Profile and Key Stats
Latest funding round on record: Apr 2022.
Octant Bio Funding Rounds
Octant Bio raised $30.0M in an undisclosed round announced in May 2020.
1.9 years later, a Series B of $80.0M was announced in Apr 2022.
Octant Bio Founders and Leadership Team
Contact details for the Octant Bio team: 1 of 1 has an email address on file.
Start 14-day free trial →Octant Bio Funding Compared to Other Biotechnology Startups
Octant Bio's latest round of $80.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Octant Bio in Biotechnology and Los Angeles
Companies Similar to Octant Bio
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Octant Bio Funding FAQs
What does Octant Bio do?
Octant Bio is a developer of synthetic technology used to improve health and treat disease. Its technology uses synthetic biology, genome engineering, next-generation sequencing, and computational tools to simultaneously measure the activity of thousands of receptor pathways in human cells that enable scientists to apply machine learning methods to engineer small molecules that interact with multiple receptors and unlock a new potential to treat complex diseases.
How much funding has Octant Bio raised?
Octant Bio has raised $110M across 2 rounds on record. The most recent is a Series B of $80.0M announced in Apr 2022.
When did Octant Bio last raise funding?
Octant Bio's most recent funding round on record is a Series B of $80.0M, announced in Apr 2022.
Who is the CEO of Octant Bio?
Sri Kosuri is listed as CEO at Octant Bio.
Where is Octant Bio headquartered?
Octant Bio is based in Los Angeles, California, United States.
How many employees does Octant Bio have?
Octant Bio is in the 51-100 employee band.
How does Octant Bio's funding compare to other Biotechnology startups?
Octant Bio's latest round of $80.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Octant Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Octant Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.